Biological screening of natural products and drug innovation in China

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 362, Issue 1482, 2007, Pages 1093-1105

  Wang, Ming Wei ^a   Hao, Xiaojiang ^b   Chen, Kaixian ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

Clinical trial; Drug screening; High throughput technologies; Natural products; Therapeutics; Traditional Chinese medicine

Indexed keywords

BIOASSAY; DRUG DEVELOPMENT; LIFE SCIENCE; MEDICINE; SCIENCE AND TECHNOLOGY;

ASIA; CHINA; EURASIA; FAR EAST;

BIOLOGICAL PRODUCT;

CHINA; CHINESE MEDICINE; HUMAN; ISOLATION AND PURIFICATION; NEOPLASM; REVIEW; SYNTHESIS;

BIOLOGICAL PRODUCTS; CHINA; HUMANS; MEDICINE, CHINESE TRADITIONAL; NEOPLASMS;

EID: 34347388239     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2007.2036     Document Type: Review

References (93)

1. A, J. Y., Wang, G. J., Liu, X. Q., Jiang, D. Y. & Liu, J. H. 2002 Study on the metabolite of guanfu base A hydrochloride in rat urine by high performance liquid chromatograph-mass spectrum. Acta Pharmacol. Sin. 37, 283-287.
2. A, J. Y., Wang, G. J., Sun, J. G., Gu, Y. C., Wu, M. S. & Liu, J. H. 2003 Identification of phase I and phase II metabolites of guanfu base A hydrochloride in human urine. Eur. J. Drug Metab. Pharmacokinet. 28, 265-272.
3. Birdsall, T. C. & Kelly, G. S. 1997 Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Altern. Med. Rev. 2, 94-103.
4. Braquet, P. G. 1985 Bn-52021 and related compounds: a new series of highly specific PAF-acether receptor antagonists. Int. J. Immunopharmacol. 7, 384. (doi:10.1016/0192-0561(85)90411-4)
5. Brossi, A., Venugopalan, B., Gerpe, L. D., Yeh, H. J. C., Flippen-Anderson, J. L., Buchs, P., Luo, X. D., Milhous, W. & Peters, W. 1988 Arteether, a new antimalarial drug: synthesis and antimalarial properties. J. Med. Chem. 31, 645-650. (doi:10.1021/jm00398a026)
6. Campiani, G., Sun, L. Q., Kozikowski, A. P., Aagaard, P. & McKinney, M. 1993 A palladium-catalyzed route to huperzine A and its analogues and their anticholinesterase activity. J. Org. Chem. 58, 7660-7669. (doi:10.1021/jo00079a008)
7. Chen, W. & Chen, W. Z. 1998 Discovery of specific bradycardic agent from traditional Chinese medicine. Chin. Pharm. J. 33, 132-134.
8. Chen, J. L., Hu, L. H., Jiang, H. L., Gu, J. D., Zhu, W. L., Chen, Z. L., Chen, K. X. & Ji, R. Y 1998 A 3D-QSAR study on ginkgolides and their analogues with comparative molecular field analysis. Bioorg. Med. Chem. Lett. 8, 1291-1296. (doi:10.1016/S0960-894X(98)00205-4)
9. Chen, R. M., Hu, L. H., An, T. Y., Li, J. & Shen, Q. 2002 Natural PTP1B inhibitors from Broussonetia papyrifera. Bioorg. Med. Chem. Lett. 12, 3387-3390. (doi:10.1016/S0960-894X(02)00757-6)
10. Creasey, W. A. 1979 Biochemical effects of berberine. Biochem. Pharmacol. 28, 1081-1084. (doi:10.1016/0006-2952(79)90308-3)
11. Deng, S. X. & Mo, Y. J. 1979 Pharmacological studies on Gastrodia elata Bluma. I. The sedative and anticonvulsant effects of synthetic gastrodin and its genin. Acta Bot. Yunnan. 1, 66-73.
12. Dhingra, V., Vishweshwar, R. K. & Lakshmi, N. M. 2000 Current status of artemisinin and its derivatives as antimalarial drugs. Life Sci. 66, 279-300. (doi:10.1016/S0024-3205(99)00356-2)
13. Eisenbrand, G., Hippe, F., Jakobs, S. & Muehlbeyer, S. 2004 Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J. Cancer Res. Clin. Oncol. 130, 627-635. (doi:10.1007/s00432-004-0579-2)
14. Foungbe, S., Kouassi, G., Kablan, J. B. & Marcy, R. 1991 Study of Costus lucanusianus: plant juice, fraction combinations and pharmacologic estimation of natural product total activity. J. Ethnopharmacol. 33, 221-226. (doi:10.1016/0378-8741(91)90080-W)
15. Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S. & Fujiwara, H. 1999 Inhibition of activator protein 1 activity by berberine in human hepatoma cells. Planta Med. 65, 381-383.
16. Fung, K. P., Zeng, L. H., Wu, J., Wong, H. N., Lee, C. M., Hon, P. M. & Chang, H. M. 1993 Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sci. 52, PL239-PL244. (doi:10.1016/0024-3205(93)90471-E)
17. Ghosh, A. K., Bhattacharyya, F. K. & Ghosh, D. K. 1985 Leismania donovani: amastigote inhibition and mode of action of berberine. Exp. Parasitol. 60, 404-413. (doi:10.1016/0014-4894(85)90047-5)
18. Guan, W. B., Huang, W. J., Zhou, Y. C. & Gong, J. Z. 1982 Effect of artemisinin and its derivatives on Plasmodium falciparum in vitro. Acta Pharmacol. Sin. 3, 139-141.
19. Han, Z. H., Wu, X. S., Zhu, X. L., Jia, S. J., Fang, D. P., Hu, R., Kang, J. P., Wang, J. & Lu, Q. 2003 Observation of guanfu base A (GFA) hydrochloride injection in treatment of paroxysmal supraventricular tachycardia. Chin. J. New Drug Clin. 12, 939-940.
20. Harvey, A. L. 1999 Medicines from nature: are natural products still relevant to drug discovery? Trends Pharmacol. Sci. 20, 196-198. (doi:10.1016/S0165-6147(99)01346-2)
21. Houston, J. G. & Banks, M. 1997 The chemical-biological interface: developments in automated and miniaturized screening technology. Curr. Opin. Biotechnol. 8, 734-740. (doi:10.1016/S0958-1669(97)80128-0)
22. Hsieh, M. T., Wu, C. R. & Chen, C. F. 1997 Gastrodin and p-hydroxybenzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats. J. Ethnopharmacol. 56, 45-54. (doi:10.1016/S0378-8741(96)01501-2)
23. Hughes, D. 1998 New HTS imaging technology deal. Drug Discov. Today 3, 438-439. (doi:10.1016/S1359-6446(98)01249-5)
24. Ji, H., Chen, H. S. & Huang, J. M. 1995 Application of berberine in cardiovascular disease. Fujian Med. J. 17, 230-231.
25. Kamata, K., Noguchi, M. & Nagai, M. 1994 Hypotensive effects of lithospermic acid B isolated from the extract of Salviae miltiorrhizae Radix in the rat. Gen. Pharmacol. 25, 69-73.
26. Keith, C. T., Borisy, A. A. & Stockwell, B. R. 2005 Multicomponent therapeutics for networked systems. Nature Rev. Drug Discov. 4, 71-78. (doi:10.1038/nrd1609)
27. Kell, D. 1999 Screensavers: trends in high-throughput analysis. Trends Biotechnol. 17, 89-91. (doi:10.1016/S0167-7799(98)01273-6)
28. Klayman, D. L. 1985 Qinghaosu (artemisinin): an antimalarial drug from China. Science 228, 1049-1055. (doi:10.1126/science.3887571)
29. Kong, W J. et al. 2004 Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10, 1344-1351. (doi:10.1038/nm1135)
30. Kozikauski, A. P., Xia, Y., Rajirathnam, R. E., Tuckmantel, W., Hanin, I. & Tang, X. C. 1991 Synthesis of huperzine A and its analogues and their antiacetylcholinesterase activity. J. Org. Chem. 56, 4636-4645. (doi:10.1021/jo00015a014)
31. Lai, H., Sasaki, T., Singh, N. P. & Messay, A. 2005 Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci. 76, 1267-1279. (doi:10.1016/j.lfs.2004.08.020)
32. Lawrence, R. N. 1999 Rediscovering natural product biodiversity. Drug Discov. Today 4, 449-451. (doi:10.1016/S1359-6446(99)01405-1)
33. Li, Y. 2002 Pharmacological studies and clinical application of bicyclol. Infect. Dis. Inform. 15, 60-61.
34. Li, M. & Liu, G. T. 2004 Inhibition of Fas/FasL mRNA expression and TNF-α release in concanavalin A-induced liver injury in mice by bicyclol. World J. Gastroenterol. 10, 1775-1779.
35. Li, Y., Yu, P. L., Chen, Y. X., Li, L. Q., Gai, Y. Z., Wang, D. S. & Zheng, Y. P. 1981 Studies on analogues of artemisinin. Acta Pharmacol Sin. 16, 429-439.
36. Li, Y et al. 2001 Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle. Bioorg. Med. Chem. Lett. 11, 5-8. (doi:10.1016/S0960-894X(00)00578-3)
37. Lin, J. G., Chung, J. G., Wu, L. T., Chen, G. W., Chang, H. L. & Wang, T. F. 1999 Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. Am. J. Chin. Med. 27, 265-275. (doi:10.1142/S0192415X99000306)
38. Liska, D. J. 1998 The detoxification enzyme systems. Altern. Med. Rev. 3, 187-198.
39. Liu, G. T. 2001 The anti-virus and hepatoprotective effect of bicyclol and its mechanism of action. Chin. J. New Drug Clin. 10, 325-327.
40. Liu, G. T. 2002 Bicyclol tablets: class I new drug for hepatitis in China. Infect. Dis. Inform. 15, 3-4.
41. Liu, J. M., Ni, M. Y., Fan, J. F., Tu, Y. Y., Wu, Z. H., Wu, Y. L. & Zhou, W. S. 1979 The structure and reaction of arteannuin. Acta Chim. Sin. 37, 129-141.
42. Liu, W. J., Jiang, J. F., Xiao, D. & Ding, J. 2002 Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochem. Pharmacol. 64, 1677-1687. (doi:10.1016/S0006-2952(02)01424-7)
43. Liu, W. J., Zhang, Y.-W., Shen, Y., Jiang, J.-F., Miao, Z.-H. & Ding, J. 2004 Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells. Biochem. Biophys. Res. Commun. 323, 660-667. (doi:10.1016/j.bbrc.2004.08.135)
44. Liu, G. T., Li, Y., Wei, H. L., Lu, H., Zhang, H., Gao, Y. G. & Wang, L. Z. 2005 Toxicity of novel anti-hepatitis drug: a preclinical study. World J. Gastroenterol. 11, 665-671.
45. Lu, G. P., Wang, C. Q. & Cai, Z. Q. 2002 Pharmacological and clinical studies on injectable gastrodin. Chin. Tradit. Herb. Drugs 33, S3-S5.
46. Lu, H.-R., Meng, L.-H., Huang, M., Zhu, H., Miao, Z.-H. & Ding, J. 2005 DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells. Cancer Chemother. Pharmacol. 55, 286-294. (doi:10.1007/s00280-004- 0877-z)
47. Marin-Neto, J. A., Maciel, B. C., Seeches, A. L. & Gallo, L. 1988 Cardiovascular effects of berberine in patients with severe congestive heart failure. Clin. Cardiol. 11, 253-260.
48. Maruyama, M., Terahara, A., Itagaki, Y. & Nakanishi, K. 1967a The ginkgolides. I. Isolation and characterization of the various groups. Tetrahedron Lett. 8, 299-302. (doi:10.1016/S0040-4039(00)71538-3)
49. Maruyama, M., Terahara, A., Itagaki, Y. & Nakanishi, K. 1967b The ginkgolides. II. Derivation of partial structures. Tetrahedron Lett. 8, 303-308. (doi:10.1016/S0040-4039(00)71539-5)
50. Maruyama, M., Terahara, A., Itagaki, Y & Nakanishi, K. 1967c The ginkgolides. III. The structure of ginkgolides. Tetrahedron Lett. 8, 309-313. (doi:10.1016/S0040-4039(00)71540-1)
51. McCluskey, A., Bowyer, M. C., Collins, E., Sim, A. T. R., Sakoff, J. A. & Baldwin, M. L. 2000 Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity. Bioorg. Med. Chem. Lett. 10, 1687-1690. (doi:10.1016/S0960-894X(00)00323-1)
52. Meng, L. H., He, X. X., Zhang, J. S. & Ding, J. 2001 DNA topoisomerase II as the primary cellular target for salvicine in Saccharomyces cerevisiae. Acta Pharmacol. Sin. 22, 741-746.
53. Miao, Z. H. & Ding, J. 2003 Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Res. 63, 4527-4532.
54. Miao, Z. H., Tang, T., Zhang, Y. X., Zhang, J. S. & Ding, J. 2003 Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells. Int. J. Cancer 106, 108-115. (doi:10.1002/ijc.11174)
55. Pharmacopoeia Commission of People's Republic of China. 1995 Pharmacopoeia of People's Republic of China, pp. 45-46. Guangzhou/Beijing: Guangdong Science & Technology Press/Chemical Industry Press.
56. Qing, C., Zhang, J. S. & Ding, J. 1999 In vitro cytotoxicity of salvicine, a novel diterpenoid quinone. Acta Pharmacol. Sin. 20, 297-302.
57. Qing, C., Jiang, C., Zhang, J. S. & Ding, J. 2001 Induction of apoptosis in human leukemia K-562 and gastric carcinoma SGC-7901 cells by salvicine, a novel anticancer compound. Anticancer Drugs 12, 51-56. (doi:10.1097/00001813-200101000-00007)
58. Sack, R. B. & Froelich, J. L. 1982 Berberine inhibits intestinal secretory response of Vibrio cholera and Escherichia coli enteroxins. Infect. Immun. 35, 471-475.
59. Schuster, B. G. 2001 A new integrated program for natural product development and the value of an ethnomedical approach. J. Altern. Complem. Med. 7, S61-S72. (doi:10.1089/107555301753393823)
60. Singh, N. P. & Lai, H. 2001 Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci. 70, 49-56. (doi:10.1016/S0024-3205(01)01372-8)
61. Sittampalam, G. S., Kahl, S. D. & Janzen, W. P. 1997 High-throughput screening: advances in assay technologies. Curr. Opin. Chem. Biol. 1, 384-391. (doi:10.1016/S1367-5931(97)80078-6)
62. Sundberg, S. A. 2000 High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. Curr. Opin. Biotechnol. 11, 47-53. (doi:10.1016/S0958-1669(99)00051-8)
63. Tang, L. 2000 Studies on indirubin and its derivatives. Acta Univ. Sci. Med. Chongqing 25, 219-221.
64. Tang, M.-K., Ren, D.-C., Zhang, J.-T. & Du, G.-H. 2002 Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 9, 405-409. (doi:10.1078/09447110260571634)
65. Turner, D. M. 1996 Natural product source material use in the pharmacological industry: the Glaxo experience. J. Ethnopharmacol. 51, 39-43. (doi:10.1016/0378-8741(95)01348-2)
66. Utzinger, J., N'Goran, E. K., N'Dri, A., Lengeler, L., Xiao, S. & Tanner, M. 2000 Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 355, 1320-1325. (doi:10.1016/S0140-6736(00)02114-0)
67. Utzinger, J., Xiao, S., N'Gorand, E. K., Bergquist, R. & Tannera, M. 2001 The potential of artemether for the control of schistosomiasis. Int. J. Parasitol. 31, 1549-1562. (doi:10.1016/S0020-7519(01)00297-1)
68. Wang, G. S. 1980 The clinical studies of Canthairidin. Acta Pharmacol. Sin. 15, 119-123.
69. Wang, Z. Y. 2003 Ham-Wasserman lecture: treatment of acute leukemia by inducing differentiation and apoptosis. Hematology (American Society of Hematology Education Program) 2003, 1-13.
70. Wang, M.-W. 2005 Biological screening of medicinal plants. In Handbook of medicinal plants (eds Z. Yaniv & U. Bachrach), pp. 213-233. New York, NY: Haworth Press.
71. Wang, C. C., Wu, C. H., Hsieh, K. J., Yen, K. Y. & Yang, L. L. 2000a Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells. Toxicology 147, 77-87. (doi:10.1016/S0300- 483X(00)00185-2)
72. Wang, W., Wang, Y. P., Sun, W. K., Xu, Y. M. & Xuan, L. J. 20006 Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets. Acta Pharmacol. Sin. 21, 859-863.
73. Weinges, K., Hepp, M. & Jaggy, H. 1987 Chemistry of ginkgolides. II. Isolation and structural elucidation of a new ginkgolide. Liebigs Ann. Chem. 6, 521-526.
74. Wu, X. J., Wang, Y. P., Wang, W., Sun, W. K., Xu, Y. M. & Xuan, L. J. 2000 Free radical scavenging and inhibition of lipid peroxidation by magnesium lithospermate B. Acta Pharmacol. Sin. 21, 855-858.
75. Xiao, S., Tanner, M., N'Goran, E. K., Utzinger, J., Chollet, J., Bergquist, R., Chen, M. G. &. Zheng, J. 2002a Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Tropica 82, 175-181. (doi:10.1016/S0001-706X(02)00009-8)
76. Xiao, S., Shen, B. G., Utzinger, J., Chollet, J. & Tanner, M. 2002b Transmission electron microscopic observations on ultrastructural damage in juvenile Schistosoma mansoni caused by artemether. Acta Tropica 81, 53-61. (doi:10.1016/S0001-706X(01)00187-5)
77. Xu, H. X., Zhu, J., Huang, D. Z. & Zhou, W. S. 1983 Studies on structure and syntheses of arteanniun and related compound. X. The stereocontrolled synthesis of arteannuin and deoxyarteannuin. Acta Chim. Sin. 41, 574-575.
78. Xu, H. X., Zhu, J., Huang, D. Z. & Zhou, W. S. 1984 Studies on structure and syntheses of arteanniun and related compound. XVII. The stereocontrolled total synthesis of methal dihydroarteannuate-the total synthesis of arteannuin. Acta Chim. Sin. 42, 940-942.
79. 2+ current of single ventricular myocyte from guinea pig. Chin. J. Pharmacol. Toxicol. 10, 81-84.
80. Yang, L. M., Xiao, Y. L. & Ou-Yang, J. H. 2003 Inhibition of magnesium lithospermate B on the c-Jun N-terminal kinase 3 mRNA expression in cardiomyocytes encountered ischemia/reperfusion injury. Acta Pharmacol. Sin. 38, 487-491.
81. Yao, G. B., Ji, Y. Y., Wang, Q. H., Zhou, X. Q., Xu, D. Z., Chen, X. Y. & Zhang, Q. B. 2002 A randomized double-blind controlled trial of bicyclol in treatment of chronic hepatitis B. Chin. J. New Drug Clin. 21, 457-462.
82. Yeung, K. K., Zhu, D. Y., O, K. & Siow, Y. L. 2001 Inhibition of stress-activated protein kinase in the ischemic/reperfused heart: role of magnesium tanshinoate B in preventing apoptosis. Biochem. Pharmacol. 62, 483-493. (doi:10.1016/S0006-2952(01)00686-4)
83. Yokozawa, T., Lee, T. W., Oura, H., Nonaka, G. & Nishioka, I. 1992 Effect of magnesium lithospermate B in rats with sodium-induced hypertension and renal failure. Nephron 60, 460-165.
84. Yuan, R. & Lin, Y. 2000 Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol. Ther. 86, 191-198. (doi:10.1016/S0163-7258(00)00039-5)
85. Zhang, P., Wang, S. Y. & Hu, L. H. 1995 Arsenic trioxide treated 72 cases of acute promyelocytic leukemia. Chin. J. Hematol. 17, 58-62.
86. Zhang, J.-S., Ding, J., Tang, Q.-M., Li, M., Zhao, M., Lu, L.-J., Chen, L.-J. & Yuan, S.-T. 1999 Synthesis and antitumour activity of novel diterpenequinone salvicine and the analogs. Bioorg. Med. Chem. Lett. 9, 2731-2736. (doi:10.1016/S0960-894X(99)00472-2)
87. Zhao, Y. K., Cao, Q.-E., Xiang, Y. Q. & Hu, Z. D. 1999 Identification and determination of active components in Gastrodia elata B1. by capillary electrophoresis. J. Chromatogr. A 849, 277-283. (doi:10.1016/S0021-9673(99)00534-8)
88. Zhou, W. & Ruigrok, T. J. 1990 Protective effect of Danshen during myocardial ischemia and reperfusion: an isolated rat heart study. Am. J. Chin. Med. 18, 19-24. (doi:10.1142/S0192415X90000046)
89. Zhou, J., Yang, Y. B. & Yang, C. R. 1979 Chemical studies on Gastrodia elata Blume. I. Isolation and characterization of chemical components. Acta Chim. Sin. 37, 183-189.
90. Zhou, J., Yang, Y. B. & Yang, C. R. 1980 Chemical studies on Gastrodia elata Blume. II. Synthesis of gastrodin and its derivatives. Acta Chim. Sin. 38, 160-166.
91. Zhou, G.-B., Zhao, W.-L., Wang, Z.-Y., Chen, S.-J. & Chen, Z. 2005 Retinoic acid and arsenic for treating acute promyelocytic leukemia. PLoS Med. 2, 0033-0038. (doi:10.1371/journal.pmed.0020012)
92. Zhu, D. Y. 2004 Structure modification of natural products. In Natural Product Chemistry (eds R. S. Xu, Y. Ye & W. M. Zhao), pp. 759-760, 2nd edn. Beijing, China: Science Press.
93. Zhu, D. Y. et al. 1999 Huperzine A derivatives, their preparation and their use. United States Patent Number 5,929,084.